GBA1 and Parkinson disease: However, at this point we lack direct comparisons with the same assay/methodology evaluating the degree of GCase activity reduction, lysosomal dysfunction, and consecutive alpha-synuclein accumulation between wild-type and different genetic forms of PD (GBA, LRKK2, Parkin, PINK, etc.).